The reduction of nosocomial MRSA infection in Germany: An analysis of data from the Hospital Infection Surveillance System (KISS) between 2007 and 2012;Rückgang von nosokomialen MRSA-infektionen in Deutschland: Analyse aus dem Krankenhaus-Infektions-Surveillance-System (KISS) der jahre 2007-2012

Deutsches Arzteblatt International

Volumn 111, Issue 19, 2014, Pages 331-336

  Meyer, Elisabeth ^a   Schröder, Christin ^b,c   Gastmeier, Petra ^b,c   Geffers, Christine ^b,c  

^a Institute of Hygiene   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c German National Reference Center for Surveillance of Nosocomial Infections   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; GERMANY; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; RESPIRATORY TRACT INFECTION; SEPSIS; STAPHYLOCOCCUS INFECTION; SURGICAL INFECTION; SURGICAL WARD; URINARY TRACT INFECTION; ADOLESCENT; ADULT; AGED; CATHETER-RELATED INFECTIONS; CHILD; CROSS INFECTION; EPIDEMIC; FEMALE; HEALTH SURVEY; INFANT; INTENSIVE CARE; LONGITUDINAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; PREVALENCE; RISK FACTOR; STAPHYLOCOCCAL INFECTIONS; STATISTICS AND NUMERICAL DATA; SURGICAL WOUND INFECTION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CATHETER-RELATED INFECTIONS; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; DISEASE OUTBREAKS; FEMALE; GERMANY; HUMANS; INFANT; INFANT, NEWBORN; INTENSIVE CARE; LONGITUDINAL STUDIES; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; POPULATION SURVEILLANCE; PREVALENCE; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; SURGICAL WOUND INFECTION; YOUNG ADULT;

EID: 84901794882     PISSN: 18660452     EISSN: None     Source Type: Journal    
DOI: 10.3238/arztebl.2014.0331     Document Type: Article

References (28)

1. Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013. http://www.cdc.gov/drugresistance/threat-report- 2013/pdf/ar-threats-2013-508.pdf. Last accessed on 24. February 2014.
2. Public Health England. Mandatory Surveillance of Staphylococcus aureus bacteraemia, 2013. www.hpa.org.uk/web/HPAweb&Page&HPAwebAutoListName/ Page/1191942169773. Last accessed on 24. February 2014.
3. Jarlier V, Trystram D, Brun-Buisson C, et al.: Curbing methicillin-resistant Staphylococcus aureus in 38 French hospitals through a 15-year institutional control program. Arch Intern Med 2010; 170: 552.
4. Johnson AP: Methicillin-resistant Staphylococcus aureus: the European landscape. J Antimicrob Chemother 2011; 66: 43.
5. Jarvis WR, Jarvis AA, Chinn RY: National prevalence of methicillin-resistant Staphylococcus aureus in inpatients at United States health care facilities, 2010. Am J Infect Control 2012; 40: 194.
6. Schweizerisches Zentrum für Antibiotikaresistenzen. Resistenzdaten Humanmedizin. http://www.anresis.ch/de/index.html. Last accessed on 24. February 2014.
7. Mattner F, Bange FC, Meyer E, Seifert H, Wichelhaus TA, Chaberny IF: Preventing the spread of multidrug-resistant gram-negative pathogens: Recommendations of an expert panel of the german society for hygiene and microbiology. Dtsch Arztebl Int 2012; 109(3): 39-45.
8. Ott E, Saathoff S, Graf K, Schwab F, Chaberny IF: The prevalence of nosocomial and community acquired infections in a university hospital - an observational study. Dtsch Arztebl Int 2013; 110(31-32): 533-40.
9. Köck R, Mellmann A, Schaumburg F, Friedrich AW, Kipp F, Becker K: The epidemiology of methicillin-resistant staphylococcus aureus (MRSA) in Germany. Dtsch Arztebl Int 2011; 108(45): 761-7.
10. Meyer E, Gastmeier P, Schwab F: The burden of multiresistant bacteria in German intensive care units. J Antimicrob Chemother 2008; 62: 1474-6.
11. Meyer E, Schwab F, Schroeren-Boersch B, Gastmeier P: Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008. Crit Care 2010; 14; 14: R113.
12. Statistik-Portal. Anzahl der Krankenhäuser in Deutschland in den Jahren 2000 bis 2012. http://de.statista.com. Last accessed on 24. February 2014.
13. Zuschneid I, Rücker G, Schoop R, et al.: Representativeness of the surveillance data in the intensive care unit component of the German nosocomial infections surveillance system. Infect Control Hosp Epidemiol 2010; 31: 934-8.
14. Geffers C, Gastmeier P: Nosocomial infections and multidrug-resistant organisms in Germany: epidemiological data from KISS (the Hospital Infection Surveillance System). Dtsch Arztebl Int 2011; 108 (6): 87.
15. Robert Koch-Institut. Antibiotika Resistenz Surveillance. https://ars.rki.de/CommonReports/Resistenzentwicklung.aspx. Last accessed on 24. February 2014.
16. Paul Ehrlich Gesellschaft. Resistenzdaten. http://www.p-e-g.org/econtext/ resistenzdaten. Last accessed on 24. February 2014.
17. Nationales Referenzzentrum für Surveillance von nosokomialen Infektionen. MRSA-KISS. http://www.nrz-hygiene.de/surveillance/kiss/mrsa-kiss. Last accessed on 24. February 2014.
18. Meyer E, Gastmeier P, Deja M, Schwab F: Antibiotic consumption and resistance: data from Europe and Germany. Int J Med Microbiol 2013; 303: 388.
19. GERMAP. Antibiotikaverbrauch und die Verbreitung von Antibiotikaresistenzen in der Human- und Veterinärmedizin in Deutschland, 2010. http://www.p-e-g.org/econtext/germap. Last accessed on 24. February 2014.
20. Robert Koch-Institut. Eigenschaften, Häufigkeit und Verbreitung von MRSA in Deutschland - Update 2011/2012. Epidemiologisches Bulletin 2013; 21: 187.
21. European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2011, 2012. http://www.ecdc. europa.eu/en/publications/publications/antimicrobial-resistance-surveillance- europe-2011.pdf. Last accessed on 24. February 2014.
22. Edgeworth JD: Has decolonization played a central role in the decline in UK methicillin-resistant Staphylococcus aureus transmission? A focus on evidence from intensive care. J Antimicrob Chemother 2011; 66: 41.
23. Johnson AP, Davies J, Guy R, et al.: Mandatory surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in England: the first 10 years. J Antimicrob Chemother 2012; 67: 802.
24. Carlet J, Astagneau P, Brun-Buisson C, et al.: French national program for prevention of healthcare-associated infections and antimicrobial resistance, 1992-2008: positive trends, but perseverance needed. Infect Control Hosp Epidemiol 2009; 30: 737.
25. Donker T, Wallinga J, Slack R, Grundmann H: Hospital networks and the dispersal of hospital-acquired pathogens by patient transfer. PLoS One 2012; 7: e35002.
26. Pohle M, Bär W, Bühling A, et al.: Untersuchung der MRSA-Prävalenz in der Bevölkerung im Bereich des lokalen MRE-Netzwerkes Südbrandenburg. Epidemiologisches Bulletin 2012; 8: 63.
27. Herrmann M, Petit C, Dawson A, et al.: Methicillin-resistant Staphylococcus aureus in Saarland, Germany: A statewide admission prevalence screening study. PLoS One 2013; 8: e73876.
28. GERMAP. Bericht über den Antibiotikaverbrauch und die Verbreitung von Antibiotikaresistenzen in der Human- und Veterinärmedizin in Deutschland, 2008. www.bvl.bund.de/SharedDocs/Downloads/08-PresseInfothek/ Germap-2008.pdf. Last accessed on 24. February 2014.